期刊文献+

人类免疫缺陷病毒感染者冠心病危险因素研究现况 被引量:6

原文传递
导出
摘要 2011年全球艾滋病患者死亡人数为170万,较2005年下降约24%[1].我国为2.1万人,较前上升11.8%[2],我国艾滋病防治工作形势依然严峻.其中,人类免疫缺陷病毒(human immunodeficiency virus,HIV)感染人群中心血管疾病,尤其是冠心病的发病率和死亡率逐年增加[3],其心肌梗死的死亡率约为普通人群的1.5 -1.7倍,平均中位死亡年龄约为48岁,远远低于普通人群[4-5].尽管HIV感染者对冠心病的传统危险因素风险认知水平很高,但这并没有降低他们冠心病的发病率,可能是由于HIV感染人群自身的特殊性所决定的[6].现分别从HIV感染者的遗传学背景、传统危险因素、HIV感染、抗逆转录病毒治疗等方面,对目前HIV感染者冠心病危险因素作一综述.
作者 兰岭 张抒扬
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2014年第11期974-976,共3页 Chinese Journal of Cardiology
  • 相关文献

参考文献2

二级参考文献33

  • 1韩扬,邱志峰,李太生,谢静,左玲燕,匡季秋,王爱霞.CD_8^+ T细胞激活分子CD_(38)、HLA-DR与HIV-1载量的相关性研究[J].中华内科杂志,2006,45(6):459-462. 被引量:23
  • 2韩扬,邱志峰,李太生,谢静,左玲燕,李雁凌,匡季秋,王爱霞.人类免疫缺陷病毒感染者及艾滋病患者CD8^+CD38^+ CD8^+HLA-DR+比例与HIV载量的相关性研究[J].中国实用内科杂志,2007,27(11):847-850. 被引量:11
  • 3Ford ES,Puronen CE,Sereti I. Immunopathogenesis of asymptomatic chronic HIV Infection:the calm before the storm.Curr Opin HIV AIDS,2009,4:206-214.
  • 4Appay V,Sauce D.Immune activation and inflammation in HIV-1 infection:causes and consequences.J Pathol,2008,214:231-241.
  • 5Wei X,Ghosh SK,Taylor ME,et al.Viral dynamics in human immunodeficiency virus type 1 infection.Nature,1995,373:117-122.
  • 6Ho DD,Neumann AU,Perelson AS,et al.Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection.Nature,1995,373:123-126.
  • 7Fernandez S,Lim A,French M.Immune activation and the pathogenesis of HIV disease:implications for therapy.J HIV Ther,2009,14:52-56.
  • 8Cassol E,Malfeld S,Mahasha P,et al.Persistent microbial translocation and immune activation in HIV-1-infected South Africans receiving combination antiretroviral therapy.J Infect Dis,2010,202:723-733.
  • 9Hammer SM,Eron JJ Jr,Reiss P,et al.Antiretroviral treatment of adult HIV infection:2008 recommendations of the International AIDS Society-USA panel.JAMA,2008,300:555-570.
  • 10Thompson MA,Aberg JA,Cabn P,et al.Antiretroviral treatment of adult HIV infection:2010 recommendations of the International AIDS Society-USA panel.JAMA,2010,304:321-333.

共引文献4

同被引文献91

  • 1田然,张抒扬.高效抗逆转录病毒治疗HIV感染者合并冠状动脉疾病研究现况[J].中华内科杂志,2006,45(10):863-865. 被引量:2
  • 2叶任高,陆再英,谢毅.内科学[M].6版.北京:人民卫生出版社,2006:384.
  • 3Wang HB, Mo QH, Yang Z. HIV vaccine research: the challenge and the way forward[J]. J Immunol Res, 2015,2015: 503978.
  • 4World Health Organization. Global report :UNAIDS repor on the global AIDS epidemic 2012 [J/OL]. 2012. http:// reliefweb.int/sites/reliefweb.int/files/resourees/20121120_ UNAIDS_Global_Report_2012_en.pdf.
  • 5Lewden C, May T, Rosenthal E, et al. Changes in causes of death among adults infected by HIV between 2000 and 2005: the "Mortalit6 2000 and 2005" surveys (ANRS EN19 and Mortavic)[J]. J Acquir Immune Defic Syndr, 2008, 48(5): 590-598.
  • 6Baekken M, Os I, Sandvik L, et al. Hypertension in an urban HIV-positive population compared with the general population: influence of combination antiretroviral therapy[J]. J Hypertens, 2008, 26(11): 2126-2133.
  • 7d'Ettorre G, Francone M, Mancone M, et al. Significant coronary stenosis detected by coronary computed angiography in asymptomatic HIV infected subjects[J]. J Infect, 2012, 64(1): 82-88.
  • 8E1-Sadr WM, Lundgren J, Neaton JD, et al. CD4^+ count- guided interruption of antiretroviral treatment[J]. N Engl J Med, 2006, 355(22): 2283-2296.
  • 9Feingold KR, Grunfeld C. The acute phase response inhibits reverse cholesterol transport[J]. J Lipid Res, 2010, 51(4): 682-684.
  • 10Ford ES, Greenwald JH, Richterman AG, et al. Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection[J]. AIDS, 2010, 24(10): 1509-1517.

引证文献6

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部